1. Castellani A. Researches on elephantiasis nostras and elephantiasis tropica with special regard to their initial stage of recurring lymphangitis (lymphangitis recurrens elephantogenica). J Trop Med Hyg. 1969. 72:89–97.
2. Sisto K, Khachemoune A. Elephantiasis nostras verrucosa: a review. Am J Clin Dermatol. 2008. 9:141–146.
3. Routh HB. Elephantiasis. Int J Dermatol. 1992. 31:845–852.
4. Schissel DJ, Hivnor C, Elston DM. Elephantiasis nostras verrucosa. Cutis. 1998. 62:77–80.
5. Choi JM, Park CJ, Yi JY. A case of elephantiasis nostras. Korean J Dermatol. 1998. 36:1098–1100.
6. Castellani A. Elephantiasis nostras. J Trop Med Hyg. 1934. 37:257–264.
Article
7. Duckworth AL, Husain J, Deheer P. Elephantiasis nostras verrucosa or "mossy foot lesions" in lymphedema praecox: report of a case. J Am Podiatr Med Assoc. 2008. 98:66–69.
Article
8. Turhan E, Ege A, Keser S, Bayar A. Elephantiasis nostras verrucosa complicated with chronic tibial osteomyelitis. Arch Orthop Trauma Surg. 2008. 128:1183–1186.
Article
9. Boyd J, Sloan S, Meffert J. Elephantiasis nostrum verrucosa of the abdomen: clinical results with tazarotene. J Drugs Dermatol. 2004. 3:446–448.
10. Bergan JJ, Schmid-Schonbein GW, Smith PD, Nicolaides AN, Boisseau MR, Eklof B. Chronic venous disease. N Engl J Med. 2006. 355:488–498.
Article
11. Chernosky ME, Derbes VJ. Elephantiasis nostras of the abdominal wall. Arch Dermatol. 1966. 94:757–762.
Article
12. Barron GS, Jacob SE, Kirsner RS. Dermatologic complications of chronic venous disease: medical management and beyond. Ann Vasc Surg. 2007. 21:652–662.
Article
13. Kakati S, Doley B, Pal S, Deka UJ. Elephantiasis Nostras Verrucosa: a rare thyroid dermopathy in Graves' disease. J Assoc Physicians India. 2005. 53:571–572.
14. Zouboulis CC, Biczo S, Gollnick H, Reupke HJ, Rinck G, Szabo M, et al. Elephantiasis nostras verrucosa: beneficial effect of oral etretinate therapy. Br J Dermatol. 1992. 127:411–416.
Article
15. Iwao F, Sato-Matsumura KC, Sawamura D, Shimizu H. Elephantiasis nostras verrucosa successfully treated by surgical debridement. Dermatol Surg. 2004. 30:939–941.
Article